Export Publications

Export the displayed publications:
Number of documents


Curriculum vitae - Séverine MORISSET - LOPEZ

Journal articles39 documents

  • Chayma El Khamlichi, Flora Reverchon-Assadi, Nadège Hervouet-Coste, Lauren Blot, Eric Reiter, et al.. Bioluminescence Resonance Energy Transfer as a Method to Study Protein-Protein Interactions: Application to G Protein Coupled Receptor Biology. Molecules, MDPI, 2019, 24 (3), pp.537. ⟨10.3390/molecules24030537⟩. ⟨hal-02067271⟩
  • Viorel Simion, Wissem Deraredj Nadim, Hélène Bénédetti, Chantal Pichon, Séverine Morisset-Lopez, et al.. Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities. Current Neuropharmacology, Bentham Science Publishers, 2017, 15 (2), pp.276 - 290. ⟨10.2174/1570159X14666160630210422⟩. ⟨hal-01618771⟩
  • Wissem Deraredj Nadim, Simion Viorel, Hélène Bénédetti, Chantal Pichon, Patrick Baril, et al.. MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?. Current Neuropharmacology, Bentham Science Publishers, 2017, 15 (2), pp.260 - 275. ⟨10.2174/1570159X14666160709001441⟩. ⟨hal-01618199⟩
  • Yacine Chebani, Candice Marion, Philippe Zizzari, Khadidja Chettab, Marie Pastor, et al.. Enhanced responsiveness of Ghsr Q343X rats to ghrelin results in enhanced adiposity without increased appetite. Science Signaling, American Association for the Advancement of Science, 2016, 9 (424), pp.ra39. ⟨10.1126/scisignal.aae0374⟩. ⟨inserm-01463897⟩
  • Wissem Deraredj Nadim, Séverine Chaumont-Dubel, Fahima Madouri, Laetitia Cobret, Marie-Ludivine de Tauzia, et al.. Physical interaction between neurofibromin and serotonin 5-HT 6 receptor promotes receptor constitutive activity. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2016, 113 (43), pp.12310 - 12315. ⟨10.1073/pnas.1600914113⟩. ⟨hal-01407899⟩
  • Emmanuel Deau, Elodie Robin, Raluca Voinea, Nathalie Percina, Grzegorz Satała, et al.. Rational Design, Pharmacomodulation, and Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT 7 )/5-Hydroxytryptamine 2A (5-HT 2A ) Receptor Antagonists and Evaluation by [ 18 F]-PET Imaging in a Primate Brain. Journal of Medicinal Chemistry, American Chemical Society, 2015, 58 (20), pp.8066-8096. ⟨10.1021/acs.jmedchem.5b00874⟩. ⟨hal-02068052⟩
  • L Cobret, M L de Tauzia, J Ferent, E Traiffort, I Hénaoui, et al.. Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling. British Journal of Clinical Pharmacology, Wiley, 2015, 172 (3), pp.841-856. ⟨10.1111/bph.12945⟩. ⟨hal-01170735⟩
  • Fanny Duhr, Paul Déléris, Fabrice Raynaud, Martial Séveno, Séverine Morisset-Lopez, et al.. Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth. Nature Chemical Biology, Nature Publishing Group, 2014, 10 (7), pp.590-597. ⟨10.1038/nchembio.1547⟩. ⟨hal-01178901⟩
  • Fabienne Godin, Sandrine Villette, Béatrice Vallée, Michel Doudeau, Séverine Morisset-Lopez, et al.. A fraction of neurofibromin interacts with PML bodies in the nucleus of the CCF astrocytoma cell line.. Biochemical and Biophysical Research Communications, Elsevier, 2012, 418 (4), pp.689-94. ⟨10.1016/j.bbrc.2012.01.079⟩. ⟨hal-00721861⟩
  • M. Picard, S. Morisset, J.F. Cloix, J.C. Bizot, M. Guerin, et al.. Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist. Neuroscience, Elsevier - International Brain Research Organization, 2010, 169 (3), pp.1337-1346. ⟨10.1016/j.neuroscience.2010.05.040⟩. ⟨hal-02071835⟩
  • F. Gbahou, E. Davenas, S. Morisset, J.- Arrang. Effects of Betahistine at Histamine H3 Receptors: Mixed Inverse Agonism/Agonism In Vitro and Partial Inverse Agonism In Vivo. Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2010, 334 (3), pp.945-954. ⟨10.1124/jpet.110.168633⟩. ⟨hal-02071192⟩
  • Mouhammad Motawaj, Aude Burban, Elisabeth Davenas, Florence Gbahou, Raphaël Faucard, et al.. Le système histaminergique : une cible pour de nouveaux traitements des deficits cognitifs. Thérapie, EDP Sciences, 2010, 65 (5), pp.415-422. ⟨10.2515/therapie/2010058⟩. ⟨hal-02071208⟩
  • W. Beghdadi, A. Porcherie, Schneider B.S., S. Morisset, D. Dubayle, et al.. Histamine H3 receptor-mediated signaling protects mice from cerebral malaria.. PLoS ONE, Public Library of Science, 2009, 4, pp.e6004. ⟨hal-00397938⟩
  • Jacques Pantel, Marie Legendre, Sylvie Nivot, Séverine Morisset, Marie Vie-Luton, et al.. Recessive Isolated Growth Hormone Deficiency and Mutations in the Ghrelin Receptor. Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2009, 94 (11), pp.4334-4341. ⟨10.1210/jc.2009-1327⟩. ⟨hal-02081574⟩
  • E. Davenas, A. Rouleau, S. Morisset, J. Arrang. Autoregulation of McA-RH7777 Hepatoma Cell Proliferation by Histamine H3 Receptors. Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2008, 326 (2), pp.406-413. ⟨10.1124/jpet.107.135368⟩. ⟨hal-02081595⟩
  • Marie Humbert-Claude, Séverine Morisset, Florence Gbahou, Jean-Michel Arrang. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPγ[S] binding in rat striatum: Evidence for additive effects but lack of interactions. Biochemical Pharmacology, Elsevier, 2007, 73 (8), pp.1172-1181. ⟨10.1016/j.bcp.2007.01.006⟩. ⟨hal-02081605⟩
  • Jean-Michel Arrang, Séverine Morisset, Florence Gbahou. Constitutive activity of the histamine H3 receptor. Trends in Pharmacological Sciences, Elsevier, 2007, 28 (7), pp.350-357. ⟨10.1016/⟩. ⟨hal-02081603⟩
  • M. Humbert-Claude, S Morisset-Lopez, F. Gbahou, M. Arrang. Potential molecular interactions between the histamine H3 receptor and the dopamine D2 receptor in the rat striatum. European Neuropsychopharmacology, Elsevier, 2006, 16, pp.S16-S17. ⟨10.1016/s0924-977x(06)80021-0⟩. ⟨hal-02082149⟩
  • J. Pantel, Marie Legendre, Sylvie Cabrol, Latifa Hilal, Yassir Hajaji, et al.. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. Journal of Clinical Investigation, American Society for Clinical Investigation, 2006, 116 (3), pp.760-768. ⟨10.1172/JCI25303⟩. ⟨hal-02082146⟩
  • S Morisset-Lopez, C. Chabret, J.M. Arrang. P.1.31 Constitutive dimerization of the histamineH3 receptor in living cells. European Neuropsychopharmacology, Elsevier, 2005, 15, pp.S25-S26. ⟨10.1016/s0924-977x(05)80136-1⟩. ⟨hal-02082151⟩
  • F. Gbahou, A. Rouleau, S Morisset-Lopez, X. Ligneau, J. Tardivel-Lacombe, et al.. P.1.03 Constitutive activity of the recombinant and native histamine H3 receptor: effects of inverse agonists and protean agonists. European Neuropsychopharmacology, Elsevier, 2004, 14, pp.S4-S5. ⟨10.1016/s0924-977x(04)90004-1⟩. ⟨hal-02081569⟩
  • Brigitte Ilien, Christelle Franchet, Philippe Bernard, Séverine Morisset, Claire Odile Weill, et al.. Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties.. Journal of neurochemistry, 2003, 85 (3), pp.768-78. ⟨hal-02081577⟩
  • J.M. Arrang, S. Morisset, A. Rouleau, F. Gbahou, X. Ligneau, et al.. Constitutive activity of the recombinant and native histamine H3 receptor. International Congress Series, Elsevier, 2003, 1249, pp.139-151. ⟨10.1016/S0531-5131(03)00617-4⟩. ⟨hal-02081573⟩
  • J.M. Arrang, S Morisset-Lopez, A. Rouleau, F. Gbahou, X. Ligneau, et al.. S.16.04 Histamine H3-receptor ligands: Effects of inverse agonists and protean ligands. European Neuropsychopharmacology, Elsevier, 2003, 13, pp.S141. ⟨10.1016/s0924-977x(03)91663-4⟩. ⟨hal-02081585⟩
  • F. Gbahou, A. Rouleau, S Morisset-Lopez, R. Parmentier, S. Crochet, et al.. Protean agonism at histamine H3 receptors in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2003, 100 (19), pp.11086-11091. ⟨10.1073/pnas.1932276100⟩. ⟨hal-02081588⟩
  • J. C. Schwartz, S Morisset-Lopez, A. Rouleau, X. Ligneau, F. Gbahou, et al.. Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor.. Journal of Neural Transmission Supplementum, Wien; New York; Springer; 1999, 2003, pp.1-16. ⟨hal-02081590⟩
  • A. Rouleau, X Ligneau, J. Tardivel-Lacombe, S Morisset-Lopez, F Gbahou, et al.. Histamine H 3 -receptor-mediated [ 35 S]GTPγ[S] binding: evidence for constitutive activity of the recombinant and native rat and human H 3 receptors. British Journal of Pharmacology, Wiley, 2002, 135 (2), pp.383-392. ⟨10.1038/sj.bjp.0704490⟩. ⟨hal-02082155⟩
  • S Morisset-Lopez, P Pilon, J. Tardivel-Lacombe, W Weinstein, W. Rostene, et al.. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.. Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2002, 300 (2), pp.621-8. ⟨hal-02082246⟩
  • C. Chotard, T. Ouimet, S. Morisset, U. Sahm, C. Schwartz, et al.. Effects of histamine H 3 receptor agonist and antagonist on histamine co-transmitter expression in rat brain. Journal of Neural Transmission, Springer Verlag, 2002, 109 (3), pp.293-306. ⟨10.1007/s007020200024⟩. ⟨hal-02081594⟩
  • Jean-Charles Schwartz, Séverine Morisset, Agnès Rouleau, Joël Tardivel-Lacombe, Florence Gbahou, et al.. Application of genomics to drug design: the example of the histamine H3 receptor. European Neuropsychopharmacology, Elsevier, 2001, 11 (6), pp.441-448. ⟨10.1016/s0924-977x(01)00121-3⟩. ⟨hal-02129745⟩
  • Séverine Morisset, Astrid Sasse, Florence Gbahou, Anne Héron, Xavier Ligneau, et al.. The Rat H3 Receptor: Gene Organization and Multiple Isoforms. Biochemical and Biophysical Research Communications, Elsevier, 2001, 280 (1), pp.75-80. ⟨10.1006/bbrc.2000.4073⟩. ⟨hal-02082164⟩
  • Joël Tardivel-Lacombe, Séverine Morisset, Florence Gbahou, Jean-Charles Schwartz, Jean-Michel Arrang. Chromosomal mapping and organization of the human histamine H3 receptor gene. NeuroReport, Lippincott, Williams & Wilkins, 2001, 12 (2), pp.321-324. ⟨10.1097/00001756-200102120-00028⟩. ⟨hal-02082162⟩
  • C Ito, S Morisset-Lopez, J-P Olié, H Lôo, M-F Poirier, et al.. Histamine H2 receptor gene variants: lack of association with schizophrenia. Molecular Psychiatry, Nature Publishing Group, 2000, 5 (2), pp.159-164. ⟨10.1038/⟩. ⟨hal-02082207⟩
  • X. Ligneau, S Morisset-Lopez, J. Tardivel-Lacombe, F Gbahou, C Ganellin, et al.. Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain.. British Journal of Pharmacology, Wiley, 2000, 131 (7), pp.1247-50. ⟨10.1038/sj.bjp.0703712⟩. ⟨hal-02081534⟩
  • S. Morisset, E. Traiffort, J. M. Arrang, J. C. Schwartz. Changes in histamine H3 receptor responsiveness in mouse brain.. Journal of Neurochemistry, Wiley, 2000, 74 (1), pp.339-46. ⟨hal-00347608⟩
  • S. Morisset, A. Rouleau, X Ligneau, F Gbahou, J. Tardivel-Lacombe, et al.. High constitutive activity of native H3 receptors regulates histamine neurons in brain.. Nature, Nature Publishing Group, 2000, 408 (6814), pp.860-4. ⟨10.1038/35048583⟩. ⟨hal-02081523⟩
  • S Morisset-Lopez, Agnés Rouleau, Anne Héron, Joël Tardivel-Lacombe, Séverine Morisset, et al.. Cloning and cerebral expression of the guinea pig histamine H3 receptor. NeuroReport, Lippincott, Williams & Wilkins, 2000, 11 (4), pp.755-759. ⟨10.1097/00001756-200003200-00020⟩. ⟨hal-02082171⟩
  • S. Morisset, U. G. Sahm, E. Traiffort, J. Tardivel-Lacombe, J. M. Arrang, et al.. Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.. Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 1999, 288 (2), pp.590-6. ⟨hal-00347619⟩
  • Séverine Morisset, Elisabeth Traiffort, Jean-Charles Schwartz. Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity. European Journal of Pharmacology, Elsevier, 1996, 315 (1), pp.R1-R2. ⟨10.1016/s0014-2999(96)00738-8⟩. ⟨hal-02081407⟩

Patents1 document

  • Séverine Morisset-Lopez, Hélène Bénédetti. TOOLS FOR THE IDENTIFICATION OF LINGO-1, LINGO-2, LINGO-3 AND LINGO-4, LIGANDS, AND USES THEREOF. France, Patent n° : WO2011121257. 2011. ⟨hal-02130935⟩